## Abstract ## Background Oral cancer has been identified as a significant public health threat. Systematic evaluation of the impact of this disease on the US population is of great importance to health care providers and policy makers. ## Methods This study used the National Cancer Data Base (N
Cancer of the oral cavity: a comparison between institutions in a developing and a developed nation
✍ Scribed by André L. Carvalho; Bhuvanesh Singh; Ronald H. Spiro; Luiz P. Kowalski; Jatin P. Shah
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 134 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
The literature suggests that the natural history of squamous cell carcinoma of the oral cavity may vary and the prognosis is different in patients from developing and developed nations. The objective of this study was to compare the clinical presentation, management, and outcome of patients with oral cancer treated at tertiary care cancer institutions in a developing nation (Brazil— Centro de Tratamento e Pesquisa Hospital do Cancer A. C. Camargo [HCACC]) with those from a developed nation (United States— Memorial Sloan‐Kettering Cancer Center [MSKCC]).
Methods.
Between January 1990 and December 1994, 602 patients underwent initial treatment in the study institutions.
Results.
Overall, patients from HCACC had a higher predominance of men (78.8% vs 54.6%; p < .001) and a higher prevalence of tobacco (88.1% vs 77.8%; p = .002) and alcohol consumption (80.9% vs 69.8%; p = .004). More patients at HCACC had advanced disease (stage III/IV; 73.4% vs 37.4%; p< .001). Even though the overall outcome was poorer in patients from HCACC (p < .001), after controlling for stage, there was not a statistically significant difference in disease‐free or overall survival between the two institutions. Only at cancer‐specific survival for early‐stage disease (stage I/II) patients showed a difference (p = .05). Moreover, clinical stage (RR, 3.7; 95% CI, 2.6–5.5) and definitive treatment (RR, 3.3; 95% CI, 2.4–4.6) were the only factors that remained as significant predictors of outcome on multivariate analysis. Finally, the rate of subsequent second primary cancers was higher in patients from HCACC (p = .03).
Conclusions.
Statistically significant differences were found in clinical presentation, tumor characteristics, and outcome in OC patients between the two institutions from a developing and developed nation. Overall outcome was poorer in HACC patients. However, after controlling for site, stage, and treatment, the outcome of these patients was similar, with the exception of a higher rate of occurrence of second primary cancers in patients from HACC. Given that the use of standard protocols of treatment offer similar outcomes, the establishment of education programs and screening measures for early diagnosis might be the best chance to improve overall outcome in OC patients in developing nations. © 2004 Wiley Periodicals, Inc. Head Neck 26: 31–38, 2004
📜 SIMILAR VOLUMES
## Abstract Large numbers of cells with unique neuronal specificity are generated during development of the central nervous system of animals. Here we discuss the events that generate cell diversity during early development of the ventral nerve cord of different arthropod groups. Neural precursors
## BACKGROUND. Approximately 33% of patients with squamous cell carcinoma of the oral cavity and oropharynx develop a recurrence. The management of recurrent tumors can be challenging to both physician and patient, at least in part due to the lack of an accurate and clinically applicable staging s
## Background: The combination of t, n, and m classifications into stage groupings is meant to facilitate a number of activities, including the estimation of prognosis and the comparison of therapeutic interventions among similar groups of cases. we tested the uicc/ajcc 5th edition stage grouping a
## Abstract To investigate the possible causal association between squamous‐cell carcinomas of the oral cavity and use of toombak, we retrospectively compared the history of use of this substance in 375 patients with squamous‐cell carcinomas of the lip, buccal cavity and floor of mouth, and 271 pat